Diamedica Therapeutics (DMAC) Q3 2024 Earnings Report

573 Followers

DMAC Q3 2024 EPS Results

Actual EPS-$0.15

Consensus EPS-$0.15

Beat/MissBeat by +<$0.01

One Year Ago EPS-$0.12

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ3 2024

Date11/13/2024

TimeAfter Close

Conference CallWednesday, November 13, 2024

DMAC Upcoming Earnings

Diamedica Therapeutics's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 18, 2026	2026 (Q3)	-0.21 / -	-0.17	―
Aug 10, 2026	2026 (Q2)	-0.20 / -0.19	-0.18	-5.56% (-0.01)
May 06, 2026	2026 (Q1)	-0.19 / -0.19	-0.18	-5.56% (-0.01)
Mar 30, 2026	2025 (Q4)	-0.18 / -0.17	-0.18	5.56% (<+0.01)
Nov 12, 2025	2025 (Q3)	-0.16 / -0.17	-0.15	-13.33% (-0.02)
Aug 12, 2025	2025 (Q2)	-0.19 / -0.18	-0.13	-38.46% (-0.05)
May 13, 2025	2025 (Q1)	-0.18 / -0.18	-0.14	-28.57% (-0.04)
Mar 17, 2025	2024 (Q4)	-0.17 / -0.18	-0.12	-50.00% (-0.06)
Nov 13, 2024	2024 (Q3)	-0.15 / -0.15	-0.12	-25.00% (-0.03)
Aug 07, 2024	2024 (Q2)	-0.16 / -0.13	-0.16	18.75% (+0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed